Background Scores for cardio-embolic and bleeding risk in patients with atrial fibrillation are described in the literature. However, it is not clear how they co-classify elderly patients with multimorbidity, nor whether and how they affect the physician's decision on thromboprophylaxis. Methods Four scores for cardio-embolic and bleeding risks were retrospectively calculated for ≥ 65 year old patients with atrial fibrillation enrolled in the REPOSI registry. The co-classification of patients according to risk categories based on different score combinations was described and the relationship between risk categories tested. The association between the antithrombotic therapy received and the scores was investigated by logistic regressions and CART analyses. Results At admission, among 543 patients the median scores (range) were: CHADS2 2 (0-6), CHA2DS2-VASc 4 (1-9), HEMORR2HAGES 3 (0-7), HAS-BLED 2 (1-6). Most of the patients were at high cardio-embolic/high-intermediate bleeding risk (...
Marcucci, M., Nobili, A., Tettamanti, M., Iorio, A., Pasina, L., Djade, C., et al. (2013). Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 24(8), 800-806 [10.1016/j.ejim.2013.08.697].
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation.
MANSUETO, Pasquale;DOMINGUEZ RODRIGUEZ, Ligia Juliana;BARBAGALLO, Mario;CORRAO, Salvatore;
2013-01-01
Abstract
Background Scores for cardio-embolic and bleeding risk in patients with atrial fibrillation are described in the literature. However, it is not clear how they co-classify elderly patients with multimorbidity, nor whether and how they affect the physician's decision on thromboprophylaxis. Methods Four scores for cardio-embolic and bleeding risks were retrospectively calculated for ≥ 65 year old patients with atrial fibrillation enrolled in the REPOSI registry. The co-classification of patients according to risk categories based on different score combinations was described and the relationship between risk categories tested. The association between the antithrombotic therapy received and the scores was investigated by logistic regressions and CART analyses. Results At admission, among 543 patients the median scores (range) were: CHADS2 2 (0-6), CHA2DS2-VASc 4 (1-9), HEMORR2HAGES 3 (0-7), HAS-BLED 2 (1-6). Most of the patients were at high cardio-embolic/high-intermediate bleeding risk (...| File | Dimensione | Formato | |
|---|---|---|---|
|
European Journal of Internal Medicine 2013 24 800-6.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
377.11 kB
Formato
Adobe PDF
|
377.11 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


